For patients with diabetes, exposure to GLP-1 RAs associated with increased risk for incident neovascular age-related macular degeneration.

GLP-1 RAs are associated with a significant decrease in apnea-hypopnea index among patients with moderate to severe OSA and without diabetes.

HealthDay News — For patients with diabetes, exposure to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with an increased risk for incident neovascular age-related macular ...

GLP-1 drugs like Ozempic are associated with a higher risk of developing wet age-related macular degeneration in people with ...

A colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a ...

These challengers are anticipated to account for roughly $70 billion of the total GLP-1 market, which is expected to be worth $200 billion by 2031. By having a deeper knowledge of the market ...

Department of Pharmacy, Guangxi Medical University Cancer Hospital, Nanning 530021, P. R. China School of Chemistry & Materials Science, Jiangsu Normal University, Xuzhou 221116, P. R. China ...

Many people struggle for years to lose weight and keep it off. Bariatric surgery and medications called GLP-1s (glucagon-like peptide-1 receptor agonists) are popular options for treating obesity.

So the, the question we're investigating in this study is whether the use of GLP-1 receptor agonists, which is *** medication for weight loss and diabetes, um, is associated with *** lower risk of ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in adults with severe mental illness, as well as having positive effects on ...

Risks for prostate cancer metastasis or death appeared lower with GLP-1 RA use compared with use of other antidiabetic drugs. Patients with prostate cancer who take glucagon-like peptide-1 ...